Table 2.
Pathway | −Log(P Value) |
---|---|
Hypoxia | |
Wnt/β-catenin signaling | 3.63 |
P2Y purigenic receptor signaling | 1.91 |
VDR/RXR activation | 1.69 |
Methylmalonyl pathway | 1.51 |
Stem cell pluripotency | 1.45 |
Cytokine treatment | |
IL-17A signaling | 2.45 |
PPAR signaling | 2.07 |
NF-κΒ signaling | 1.81 |
IL-6 signaling | 1.75 |
IL-10 signaling | 1.74 |
VDR, vitamin D receptor; RXR, retinoid X recepter; PPAR, peroxide proliferator-activated receptor.